Sign in

NCT05777954Completed

Klotho and Mineral Bone Density in Systemic Sclerosis

Klotho and Bone Mineral Density (BMD) in Systemic Sclerosis Patients: Relationship with Microvascular Damage and Fibrosis

Source: ClinicalTrials.gov · Last updated 12 Mar 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The present study recruits female patients aged 45-65 years with a diagnosis of Systemic Sclerosis according to the EULAR/ACR 2013 criteria and age and gender-matched healthy control subjects. The purpose of the study is to investigate the possible role of Klotho and other cytokines involved in the osteoimmunological control of bone turnover as a possible determinant of the microvascular damage and fibrosis observed in SSc patients

Status (registry)
Completed
Study type
Observational
Enrollment
126 (actual)
First submitted
21 Feb 2023
Start date
21 Mar 2022
Primary completion date
30 Apr 2024
Lead sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
NCT number
NCT05777954

What you commit to

  • Study type: Observational
  • Participants enrolled: 126
  • From 21 Mar 2022 to the primary completion date, 30 Apr 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Drugs able to interfere with bone turn-over (such as bisphosphonates or glucocorticoids)

Other illness

  • Chronic kidney disease
  • Liver or thyroid disease
  • Diabetes

Lab values

  • Vitamin D or Calcium supplementation

Other

  • Ongoing diuretic treatment
  • Estrogen replacing treatment

Who the study is looking for

  • Female gender
  • Systemic sclerosis diagnosis
  • Signature of the informed consent

Age in the registry: 45 years to 65 years · Sex: Female · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Division of Rheumatology, Fondazione Policlinico Universitario A.Gemelli IRCCS
Coordinator of this site? Confirm its status
RomeItalyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.